CEVA Biomune - Salmonella Outbreak and Egg Recall

US - Ensuring the safety of American consumers is a top priority at CEVA and that includes providing safe, potent, and effective vaccines to protect the nation's food supply.
calendar icon 6 October 2010
clock icon 3 minute read

CEVA says it is concerned about the recent national salmonella outbreak that has sickened nearly 1,500 people and led to the recall of 550 million eggs. In response, CEVA is working closely with leading egg producers to provide vaccines and technical guidance as part of a comprehensive salmonella prevention programme.

Poultry vaccine technology is one of our company's core specialties. For nearly 20 years, CEVA has been committed to the research, development and production of the salmonella vaccine, providing solutions to protect both human and animal health. Vaccines can greatly reduce the presence of salmonella, and therefore serve as an integral part of a total salmonella control programme. However, farms must also adopt effect rodent control and biosecurity practices, as well as strict quality control protocols, in order to fully safeguard their egg supply.

CEVA has developed a highly collaborative relationship with our customers and regulatory agencies such as the FDA. We are committed to serving as a valuable partner to both the egg industry and the government by sharing our research findings and best practices with the goal of better preventing future disease outbreaks. Our expertise in the science and prevention of food-borne illnesses provides us with a unique opportunity to build enduring relationships with our customers, serve as a trusted voice for the industry, and educate government and public stakeholders.

For a podcast from regional radio station, KCU, in which Gary Baxter (CEVA Marketing Director) talks about the expectations, click here.

© 2000 - 2024 - Global Ag Media. All Rights Reserved | No part of this site may be reproduced without permission.